COMP-Angiopoietin1 potentiates the effects of bone morphogenic protein-2 on ischemic necrosis of the femoral head in rats

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Zhou, Lu ^a,b   Yoon, Sun Jung ^a   Jang, Kyu Yun ^a   Moon, Young Jae ^a   Wagle, Sajeev ^a   Lee, Kwang Bok ^a   Park, Byung Hyun ^a   Kim, Jung Ryul ^a  

^a Chonbuk National University Medical School   (South Korea)

^b TAISHAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA3 INTEGRIN; ANGIOPOIETIN 1; BETA1 INTEGRIN; BONE MORPHOGENETIC PROTEIN 2; BOVINE SERUM ALBUMIN; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CARTILAGE OLIGOMERIC MATRIX PROTEIN ANGIOPOIETIN 1; INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; SMAD1 PROTEIN; SMAD3 PROTEIN; SMAD5 PROTEIN; UNCLASSIFIED DRUG; BMP2 PROTEIN, HUMAN; COMP-ANG1 FUSION PROTEIN; HYBRID PROTEIN; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PARAMETERS; CELL ADHESION ASSAY; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; FEMUR HEAD NECROSIS; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RADIOGRAPHY; RAT; RAT MODEL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHAM PROCEDURE; TRABECULAR BONE; VASCULAR DENSITY; WESTERN BLOTTING; ANGIOGENESIS; ANIMAL; BIOSYNTHESIS; BONE DEVELOPMENT; BONE REGENERATION; BOVINE; CRICETULUS; CULTURE TECHNIQUE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM;

RATTUS;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CATTLE; CELL CULTURE TECHNIQUES; CRICETULUS; FEMUR HEAD NECROSIS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INTEGRINS; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOCLASTS; OSTEOGENESIS; RATS; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS;

EID: 84908126118     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110593     Document Type: Article

References (43)

1. Bejar J, Peled E, Boss JH (2005) Vasculature deprivation-induced osteonecrosis of the rat femoral head as a model for therapeutic trials. Theor Biol Med Model 2: 24-38.
2. Kerachian MA, Harvey EJ, Cournoyer D, Chow TY, Seguin C (2006) Avascular necrosis of the femoral head: vascular hypotheses. Endothelium 13: 237-244.
3. McAndrew MP, Weinstein SL (1984) A long-term follow-up of Legg-Calve-Perthes disease. J Bone Joint Surg Am 66: 860-869.
4. Aya-ay J, Athavale S, Morgan-Bagley S, Bian H, Bauss F, et al. (2007) Retention, distribution, and effects of intraosseously administered ibandronate in the infarcted femoral head. J Bone Miner Res 22: 93-100.
5. Park BH, Jang KY, Kim KH, Song KH, Lee SY, et al. (2009) COMP-Angiopoietin-1 ameliorates surgery-induced ischemic necrosis of the femoral head in rats. Bone 44: 886-892.
6. Kempen DH, Lu L, Heijink A, Hefferan TE, Creemers LB, et al. (2009) Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 30: 2816-2825.
7. Valentin-Opran A, Wozney J, Csimma C, Lilly L, et al. (2002) Clinical evaluation of recombinant human bone morphogenetic protein-2. Clin Orthop Relat Res 395: 110-120.
8. Khosla S, Westendorf JJ, Oursler MJ (2008) Building bone to reverse osteoporosis and repair fractures. J Clin Invest 118: 421-428.
9. David L, Feige JJ, Bailly S (2009) Emerging role of bone morphogenetic proteins in angiogenesis. Cytokine Growth Factor Rev 20: 203-212.
10. Woo EJ (2012) Recombinant human bone morphogenetic protein-2: adverse events reported to the Manufacturer and User Facility Device Experience database. Spine J 12: 894-899.
11. Itoh K, Udagawa N, Katagiri T, Iemura S, Ueno N, et al. (2001) Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology 142: 3656-3662.
12. Kamiya N, Ye L, Kobayashi T, Lucas DJ, Mochida Y, et al. (2008) Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass. J Bone Miner Res 23: 2007-2017.
13. Vandermeer JS, Kamiya N, Aya-ay J, Garces A, Browne R, et al. (2011) Local administration of ibandronate and bone morphogenetic protein-2 after ischemic osteonecrosis of the immature femoral head: a combined therapy that stimulates bone formation and decreases femoral head deformity. J Bone Joint Surg Am 93: 905-913.
14. Cho CH, Kammerer RA, Lee HJ, Steinmetz MO, Ryu YS, et al. (2004) COMPAng1: a designed angiopoietin-1 variant with nonleaky angiogenic activity. Proc Natl Acad Sci U S A 101: 5547-5552.
15. Jeong BC, Kim HJ, Bae IH, Lee KN, Lee KY, et al. (2010) COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation. Bone 46: 479-86.
16. Youn SW, Lee SW, Lee J, Jeong HK, Suh JW, et al. (2011) COMP-Ang1 stimulates HIF-1a-mediated SDF-1 overexpression and recovers ischemic injury through BM-derived progenitor cell recruitment. Blood 117: 4376-4386.
17. Koh GY (2013) Orchestral actions of angiopoietin-1 in vascular regeneration. Trends Mol Med 19: 31-39.
18. Lee KB, Murray SS, Taghavi CE, Song KJ, Brochmann EJ, et al. (2011) Bone morphogenetic protein-binding peptide reduces the inflammatory response to recombinant human bone morphogenetic protein-2 and recombinant human bone morphogenetic protein-7 in a rodent model of soft-tissue inflammation. Spine J 11: 568-576.
19. Dallabrida SM, Ismail N, Oberle JR, Himes BE, Rupnick MA (2005) Angiopoietin-1 promotes cardiac and skeletal myocyte survival through integrins. Circ Res 96: e8-24.
20. Kamoshida G, Matsuda A, Katabami K, Kato T, Mizuno H, et al. (2012) Involvement of transcription factor Ets-1 in the expression of the a3 integrin subunit gene. FEBS J 279: 4535-4546.
21. Glowacki J (1998) Angiogenesis in fracture repair. Clin Orthop Relat Res S82- 89.
22. Gerber HP, Ferrara N (2000) Angiogenesis and bone growth. Trends Cardiovasc Med 10: 223-228.
23. Schmid J, Wallkamm B, Hammerle CH, Gogolewski S, Lang NP (1997) The significance of angiogenesis in guided bone regeneration. A case report of a rabbit experiment. Clin Oral Implants Res 8: 244-248.
24. Winet H (1996) The role of microvasculature in normal and perturbed bone healing as revealed by intravital microscopy. Bone 19: 39S-57S.
25. Duggirala SS, Rodgers JB, DeLuca PP (1996) The evaluation of lyophilized polymer matrices for administering recombinant human bone morphogenetic protein-2. Pharm Dev Technol 1: 165-174.
26. Puleo DA, Huh WW, Duggirala SS, DeLuca PP (1998) In vitro cellular responses to bioerodible particles loaded with recombinant human bone morphogenetic protein-2. J Biomed Mater Res 41: 104-110.
27. Murakami N, Saito N, Takahashi J, Ota H, Horiuchi H, et al. (2003) Repair of a proximal femoral bone defect in dogs using a porous surfaced prosthesis in combination with recombinant BMP-2 and a synthetic polymer carrier. Biomaterials 24: 2153-2159.
28. Bostrom MP (1998) Expression of bone morphogenetic proteins in fracture healing. Clin Orthop Relat Res S116-23.
29. Kakudo N, Kusumoto K, Wang YB, Iguchi Y, Ogawa Y (2006) Immunolocalization of vascular endothelial growth factor on intramuscular ectopic osteoinduction by bone morphogenetic protein-2. Life Sci 79: 1847-1855.
30. Patel ZS, Ueda H, Yamamoto M, Tabata Y, Mikos AG (2008) In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds. Pharm Res 25: 2370-2378.
31. Patel ZS, Young S, Tabata Y, Jansen JA, Wong ME, et al. (2008) Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 43: 931-940.
32. Galeano M, Deodato B, Altavilla D, Cucinotta D, Arsic N, et al. (2003) Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetologia 46: 546-555.
33. Galiano RD, Tepper OM, Pelo CR, Bhatt KA, Callaghan M, et al. (2004) Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 164: 1935-1947.
34. Thurston G, Suri C, Smith K, McClain J, Sato TN, et al. (1999) Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286: 2511-2514.
35. Cho CH, Kim KE, Byun J, Jang HS, Kim DK, et al. (2005) Long-term and sustained COMP-Ang1 induces long-lasting vascular enlargement and enhanced blood flow. Circ Res 97: 86-94.
36. Ghosh-Choudhury N, Abboud SL, Nishimura R, Celeste A, Mahimainathan L, et al. (2002) Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smaddependent BMP-2 gene transcription. J Biol Chem 277: 33361-33368.
37. Shiojima I, Walsh K (2002) Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res 90: 1243-50.
38. Koppel H, Riedl E, Braunagel M, Sauerhoefer S, Ehnert S, et al. (2011) L-carnosine inhibits high-glucose-mediated matrix accumulation in human mesangial cells by interfering with TGF-beta production and signalling. Nephrol Dial Transplant 26: 3852-3858.
39. Filvaroff E, Erlebacher A, Ye J, Gitelman SE, Lotz J, et al. (1999) Inhibition of TGF-beta receptor signaling in osteoblasts leads to decreased bone remodeling and increased trabecular bone mass. Development 126: 4267-4279.
40. Mohammad KS, Chen CG, Balooch G, Stebbins E, McKenna CR, et al. (2009) Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone. PLoS One 4: e5275.
41. Giancotti FG, Ruoslahti E (1999) Integrin signaling. Science 285: 1028-1032.
42. Zimmerman D, Jin F, Leboy P, Hardy S, Damsky C, et al. (2000) Impaired bone formation in transgenic mice resulting from altered integrin function in osteoblasts. Dev Biol 220: 2-15.
43. Lee KB, Taghavi CE, Murray SS, Song KJ, Keorochana G, et al. (2012) BMP induced inflammation: a comparison of rhBMP-7 and rhBMP-2. J Orthop Res 30: 1985-1994.